Alec Stranahan

Stock Analyst at B of A Securities

(0.72)
# 2430
Out of 5,386 analysts
32
Total ratings
Success rate
Average return
Main Sectors:
16 Stocks
Name Action PT Current % Upside Ratings Updated
BEAM Beam Therapeutics
Upgrades: Buy
42 42
16.8 150% 1 Mar 28, 2025
YMAB Y-mAbs Therapeutics
Maintains: Neutral
14 12
4.74 153.16% 5 Mar 5, 2025
CADL Candel Therapeutics
Initiates Coverage On: Buy
15
4.9 206.12% 1 Feb 7, 2025
DAWN Day One Biopharmaceu...
Maintains: Buy
28 25
6.47 286.4% 4 Jan 7, 2025
CRBU Caribou Biosciences
Maintains: Buy
13 11
1.29 752.71% 1 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
5 5
1.29 287.6% 2 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 6
3.75 60% 2 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
13 15
2.27 560.79% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
48 55
36.92 48.97% 3 Jul 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
12 18
6.37 182.57% 3 Jun 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
118 140
138.96 0.75% 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
42
8.16 414.71% 1 May 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
5 6
36.74 -83.67% 2 Dec 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
60 5
1.22 309.84% 1 Dec 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
46.98 -4.21% 1 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
58
n/a n/a 1 May 20, 2022